A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder / Sidney H. Kennedy en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.4 (Abril)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 553-563 Título : A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder Tipo de documento: texto impreso Autores: Sidney H. Kennedy, Autor ; Alla S. Avedisova, Autor ; Natalia Giménez Montesinos, Autor Fecha de publicación: 2021 Artículo en la página: pp. 553-563 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agomelatine, Depression, Placebo Resumen: A randomised placebo-controlled “dose relation study” was conducted in 549 patients who met the criteria for major depressive disorder, to evaluate the efficacy and safety of three doses regimens of agomelatine during 6 weeks: low fixed dosage (10 mg/day, n=133),... Link: ./index.php?lvl=notice_display&id=26975 [artículo] A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder [texto impreso] / Sidney H. Kennedy, Autor ; Alla S. Avedisova, Autor ; Natalia Giménez Montesinos, Autor . - 2021 . - pp. 553-563. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 553-563 Palabras clave: Agomelatine, Depression, Placebo Resumen: A randomised placebo-controlled “dose relation study” was conducted in 549 patients who met the criteria for major depressive disorder, to evaluate the efficacy and safety of three doses regimens of agomelatine during 6 weeks: low fixed dosage (10 mg/day, n=133),... Link: ./index.php?lvl=notice_display&id=26975

---

1 (1 - 1 / 1)